SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ennis SR, Rios-Vargas M, Albert NG. The Hispanic Population: 2010. 2010 Census Briefs. census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed on May 1, 2014
  • 2
    US Census Bureau. U.S. Population Projections: 2008. census.gov/population/www/projections/index.html. Accessed on May 1, 2014.
  • 3
    Nyitray A, Nielson CM, Harris RB, et al. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis. 2008;197:1676-1684.
  • 4
    Nielson CM, Harris RB, Flores R, et al. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev. 2009;18:1077-1083.
  • 5
    Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis. 2011;204:566-573.
  • 6
    Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008;113(suppl 10):2855-2864.
  • 7
    Reiter PL, Pendergraft WF 3rd, Brewer NT. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev. 2010;19:2916-2931.
  • 8
    Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:630-632.
  • 9
    Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1705-1708.
  • 10
    Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010;46:113-123.
  • 11
    Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine. 2011;29:5595-5602.
  • 12
    Reiter PL, McRee AL, Gottlieb SL, Brewer NT. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010;28:6292-6297.
  • 13
    Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years–United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:685-693.
  • 14
    Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, Brewer NT. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 2013;103:1419-1427.
  • 15
    Reiter PL, Gilkey MB, Brewer NT. HPV vaccination among adolescent males: results from the National Immunization Survey-Teen. Vaccine. 2013;31:2816-2821.
  • 16
    US Department of Health and Human Services. Healthy People 2020. healthypeople.gov/2020/default.aspx. Accessed on May 3, 2014.
  • 17
    Watts LA, Joseph N, Wallace M, et al. HPV vaccine: a comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecol Oncol. 2009;112:577-582.
  • 18
    Podolsky R, Cremer M, Atrio J, Hochman T, Arslan AA. HPV vaccine acceptability by Latino parents: a comparison of U.S. and Salvadoran populations. J Pediatr Adolesc Gynecol. 2009;22:205-215.
  • 19
    Kornfeld J, Byrne MM, Vanderpool R, Shin S, Kobetz E. HPV knowledge and vaccine acceptability among Hispanic fathers. J Prim Prev. 2013;34:59-69.
  • 20
    US Department of Health and Human Services, National Center for Health Statistics. The 2010 National Immunization Survey-Teen. Hyattsville, MD: Centers for Disease Control and Prevention; 2011.
  • 21
    US Department of Health and Human Services, National Center for Health Statistics. The 2011 National Immunization Survey-Teen. Hyattsville, MD: Centers for Disease Control and Prevention; 2012.
  • 22
    US Department of Health and Human Services, National Center for Health Statistics. The 2012 National Immunization Survey-Teen. Hyattsville, MD: Centers for Disease Control and Prevention; 2013.
  • 23
    Jain N, Singleton JA, Montgomery M, Skalland B. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep. 2009;124:642-651.
  • 24
    Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60:1117-1123.
  • 25
    Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:671-677.
  • 26
    Thomson MD, Hoffman-Goetz L. Defining and measuring acculturation: a systematic review of public health studies with Hispanic populations in the United States. Soc Sci Med. 2009;69:983-991.
  • 27
    Reiter PL, Katz ML, Paskett ED. HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities. Cancer Epidemiol Biomarkers Prev. 2012;21:2220-2230.
  • 28
    Centers for Disease Control and Prevention. Vaccines For Children Program (VFC). cdc.gov/vaccines/programs/vfc/index.html. Accessed on May 3, 2014.
  • 29
    Reiter PL, Gupta K, Brewer NT, et al. Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females. Cancer Epidemiol Biomarkers Prev. 2014;23:742-754.
  • 30
    Haupt RM, Sylvester GC. Infectious Diseases in Children: HPV Disease in Males and Vaccination: Implications and Opportunities for Pediatricians 2010. pediatricsupersite.com/view.aspx?rid=66396. Accessed on May 3, 2014.
  • 31
    US Department of Health and Human Services. The Affordable Care Act and Immunization. hhs.gov/healthcare/facts/factsheets/2010/09/The-Affordable-Care-Act-and-Immunization.html. Accessed on May 5, 2014.
  • 32
    The Fenway Institute. Promoting Human Papilloma Virus Vaccine to Prevent Genital Warts and Cancers. fenwayhealth.org/site/DocServer/PolicyFocus_HPV_v4_10.09.12.pdf?docID=9961. Accessed on May 4, 2014.
  • 33
    Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morb Mortal Wkly Rep. 2013;62:591-595.
  • 34
    Moss JL, Gilkey MB, Reiter PL, Brewer NT. Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010. Cancer Epidemiol Biomarkers Prev. 2012;21:1913-1922.
  • 35
    The President's Cancer Panel. Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States from the President's Cancer Panel. Bethesda, MD: National Cancer Institute; 2014. deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/index.htm. Accessed on May 7, 2014.
  • 36
    Gerend MA, Zapata C, Reyes E. Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation. J Adolesc Health. 2013;53:623-629.
  • 37
    Chando S, Tiro JA, Harris TR, Kobrin S, Breen N. Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. Am J Public Health. 2013;103:270-272.
  • 38
    Rothman KJ. Epidemiology: An Introduction. New York, NY: Oxford University Press; Inc.; 2002.